FDA advisers narrowly vote in favor of Pfizer's RSV vaccine for older adults, despite possible safety concerns

CNN on Missouri

Mar 1, 2023

Vaccine advisers to the US Food and Drug Administration narrowly voted Tuesday in favor of Pfizer's RSV vaccine for adults over the age of 60, paving the way for approval of the fi…